Skip to content

Participants will be enrolled in a Post Market Clinical Study where the safety and performance of skanrays anesthetic workstations will be evaluated

Post Market Clinical Study of Skanrays Anesthetic Workstations - SkanSiesta Pro - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/081197
Enrollment
60
Registered
2025-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: NIL: The clinical data collection does not involve the changes in the approved indication, it falls under the category of post-market surveillance to prospectively gather clinical data

Sponsors

Skanray Technologies Limited
Lead Sponsor
Skanray Technologies Limited
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adult and pediatric subjects of age more than two year or body weight of 10 kg above whichever is lower and of either gender.The subjects belongs to the category of ASA1 physical status shall be included. (Note: ASA2 ASA3 ASA4 and ASA5 classified physical status subjects shall be included after the completion of the pilot phase).Subject or the legally authorized representative on behalf of the subject shall be capable of understanding and signing the informed consent form

Exclusion criteria

Exclusion criteria: Subjects with age less than two year or less than 10 kg of body weight.Pregnant population shall be excluded

Design outcomes

Primary

MeasureTime frame
Assessing the adequate patient oxygenation,ventilation and delivery of anesthetic gas mixtures in accordance with need of the subjectsthroughout the surgery. Determining the performance in terms of delivered parameters against the intended or set values for the specific subject condition. Determine the possible unknown adverse events,undesirable side effects associated with use of the device.Timepoint: For 60 minutes surgery: 0,12,24,36,48,60th minute. For 120 minutes surgery: 0,24,48,72,96,120th minute. For 360 minutes surgery: 0, 36,72,108,144,180 minute.

Secondary

MeasureTime frame
Assessing the patient reported outcomes from user,collection of feedback from user and investigatorTimepoint: 7days

Countries

India

Contacts

Public ContactVasundhara R

Krishna Rajendra Hospital, Mysore

viveknayak007@gmail.com8088705464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026